Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
1.10 Up 0.01(0.92%) 4:00PM EDT
|After Hours : 1.10 0.00 (0.00%) 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 8,975   7,426   8,828   8,056  
Cost of Revenue -   -   -   -  
Gross Profit 8,975   7,426   8,828   8,056  
Operating Expenses
Research Development -  190  653  293  
Selling General and Administrative508  1,237  2,259  2,398  
Non Recurring -  1,012  794  465  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 8,467   4,987   5,122   4,900  
Income from Continuing Operations
Total Other Income/Expenses Net109  492  199  749  
Earnings Before Interest And Taxes8,576  5,479  5,321  5,649  
Interest Expense -   -   -  850  
Income Before Tax8,576  5,479  5,321  4,799  
Income Tax Expense55   -  (241)80  
Minority Interest -   -   -   -  
Net Income From Continuing Ops8,521  5,479  5,562  4,719  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 8,521   5,479   5,562   4,719  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 8,521   5,479   5,562   4,719  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.